drugset
drugset / Trial / NCT02057523

Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients

NCT02057523 ↗

Phase 4 Terminated 2 enrolled University of Illinois at Chicago Mallinckrodt · collab
NaSingle-groupOpen-labelTreatment

Summary

The goal of this study is to evaluate the benefit of ACTH (Acthar) in reducing proteinuria associated with transplant glomerulopathy in non-diabetic kidney transplant recipients.

Timeline

Start
2014-09
Primary completion
2015-03
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Acthar Peptide 80 unknown —

Indications

disease related to solid organ transplantation proteinuria